Economic burden of hemophilia B in the US: a systematic literature review

Background: Hemophilia B (HB) is a rare disease caused by congenital Factor IX (FIX) deficiency. HB requires life-long management to prevent or manage bleeding and associated morbidity. Although HB affects only a small portion of the population, it is associated with high overall cost and imposes a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Drug Assess
Hlavní autoři: Li, Nanxin (Nick), Sawyer, Eileen K., Maruszczyk, Konrad, Slomka, Marta, Burke, Tom, Martin, Antony P., O’Hara, Jamie
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2019
Témata:
Poster #27
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6764337/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21556660.2019.1658306
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky